Financial intelligence for Asia's healthcare markets
 
 
Remember me:



News

Shanghai-based biotech firm Lepu Biotech has completed a ¥1.291 billion ($186 million) Series B funding round by Riverhead Capital, Sunshine Insurance Group and Ping An Capital.
ABM Therapeutics, has raised $20 million in a Series A+ funding round led by China Growth Capital.
Jabrehoo, a Chinese integrated reproductive and genetic service company, has raised ¥100 million ($14.35 million) in a series B+ funding round led by Apricot Capital.
Global Health has announced an agreement with New South Wales Department of Communities and Justice to implement the company’s MasterCare Client Management System for the Elver Trauma Treatment Program.
Beijing-based Sherpa Healthcare Partners today announced the final closing of the oversubscribed Sherpa Healthcare Fund I, L.P.
Ping An Insurance (Group) Company of China has signed an agreement with Shionogi (Hong Kong) Company, a subsidiary of Shionogi & Co to launch joint ventures in Shanghai and Hong Kong.
Singapore-based Docquity, Southeast Asia's largest professional network of doctors, has partnered with Novartis to deliver bite-sized, continual learning, and education support to doctors across seven countries in Asia.
ASLAN Pharmaceuticals a clinical-stage immunology and oncology focused biopharmaceutical company is preparing a primary listing on the Nasdaq Global Market and will delist from the Taipei Exchange.



Features

L.E.K. Consulting’s Fabio La Mola tells HealthInvestor Asia about a healthcare market going through major changes – creating significant opportunities for investors in the region.
Edwin Tong, senior minister for health, explains how the Ministry of Health in Singapore is supporting the growth in the number of seniors with Alzheimer's.
Penny Wan, regional vice-president and general manager, Japan and APAC, Amgen, writes about the public health challenge of cardiovascular diseases.
French-based international ophthalmic optics company Essilor has signed Letters of Intent with the Royal Government of Bhutan and the Central Monastic Body to strengthen the country’s vision care infrastructure.
April Chang, country manager at Cigna Singapore, argues that wellness programmes at work can lead to reduced absenteeism, higher productivity and increased morale among employees.
Steven Fang understands how to set up a healthcare company. Not only is he chief executive and founder of ASX-listed oncology company Invitrocue, he was also the founder of Singapore-based Cordlife Group, a healthcare company which provides cord blood and cord lining banking services.
Imagine a world in which you can consult with your doctor via video. She asks for a blood sample, which can be collected and analysed from a device in your home. After that is diagnosed, the prescription is automatically sent to the pharmacy and Uber then picks it up. The time from diagnosis to drugs at your home is only 60 minutes.
The digitisation of health data through blockchain technology is a groundbreaking solution that will empower patients and provide them with better access to healthcare.


HealthInvestor Asia twitter feed


Latest analysis

Shifting sands

Fabio La Mola L.E.K. Consulting's Fabio La Mola tells HealthInvestor Asia about a healthcare market going through major changes - creating significant opportunities for investors in the region.

Read the full feature here





Free trial

HealthInvestor UK